FDA Registration
Active
🇺🇸 United States
AFP AccuLite® CLIA Test System (Ref 1975-300A and 1975-300B)
Reg #: 2020726
·
FEI: 2020726
·
Expires 2025
Products
1
Proprietary Names
6
Establishment Types
1
Classifications
1
Registration Details
- Registration Name
- MONOBIND, INC.
- Registration Number
- 2020726
- FEI Number
- 2020726
- Status
- Active
- Expiry Year
- 2025
- Initial Importer
- No
- Address
- 100 N. POINTE DR.
- City
- Lake Forest
- State
- CA
- ZIP
- 92630
- Country
- US
Owner / Operator
- Firm Name
- MONOBIND, INC.
- Operator Number
- 2020726
- Address
- 100 N. POINTE DR., --
- City
- Lake Forest
- State
- CA
- Postal Code
- 92630
- Country
- US
- Correspondent
- Alicia Jerome
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment | NSF | Class 2 | Immunology | No | 2010-09-21 |
Proprietary Names
AFP AccuLite® CLIA Test System (Ref 1975-300A and 1975-300B)
AFP/ CEA/ PSA VAST AccuBind® ELISA Test System (Ref 8425-300A and 8425-300B and 8425-300D and 8425-300E)
AFP/ hCG/ uE3 VAST AccuLite® CLIA Test System (Ref 8575-300A and 8575-300B and 8575-300D and 8575-300E)
AFP/ hCG/ uE3 VAST AccuBind® ELISA Test System (Ref 8525-300A and 8525-300B and 8525-300D and 8525-300E)
AFP AccuBind® ELISA Test System (Ref 1925-300A and 1925-300B)
AFP/ CEA/ PSA VAST AccuLite® CLIA Test System (Ref 8475-300A and 8475-300B and 8475-300D and 8475-300E)
Establishment Types
Manufacture Device in the United States for Export Only